1. Home
  2. KLTR vs CRBU Comparison

KLTR vs CRBU Comparison

Compare KLTR & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaltura Inc.

KLTR

Kaltura Inc.

HOLD

Current Price

$1.71

Market Cap

238.4M

Sector

Technology

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.66

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLTR
CRBU
Founded
2006
2011
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.4M
203.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
KLTR
CRBU
Price
$1.71
$1.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$3.50
$9.33
AVG Volume (30 Days)
348.9K
972.2K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$180,921,000.00
$9,295,000.00
Revenue This Year
$3.10
N/A
Revenue Next Year
$1.24
$4.96
P/E Ratio
N/A
N/A
Revenue Growth
1.88
N/A
52 Week Low
$1.36
$0.66
52 Week High
$2.82
$3.54

Technical Indicators

Market Signals
Indicator
KLTR
CRBU
Relative Strength Index (RSI) 55.78 37.25
Support Level $1.64 $1.82
Resistance Level $1.72 $1.74
Average True Range (ATR) 0.09 0.10
MACD 0.01 -0.00
Stochastic Oscillator 63.46 10.14

Price Performance

Historical Comparison
KLTR
CRBU

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: